| Report ID |
18692 |
| Drug Identification Number |
01927698 |
| Brand name |
NOZINAN INJ 25MG/ML |
| Common or Proper name |
Nozinan solution injectable 25 mg/ml |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
METHOTRIMEPRAZINE |
| Strength(s) |
25MG |
| Dosage form(s) |
SOLUTION |
| Route of administration |
INTRAMUSCULAR
INTRAVENOUS |
| Packaging size |
10 |
| ATC code |
N05AA |
| ATC description |
ANTIPSYCHOTICS |
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
2017-09-15 |
| Actual start date |
|
| Estimated end date |
2017-11-03 |
| Actual end date |
2017-11-09 |
| Shortage status |
Resolved |
| Updated date |
2017-11-10 |
| Company comments |
Manufacturing delay |
| Health Canada comments |
|
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
